Preventive long-term effects of a topical film-forming medical device with ultra-high uv protection filters and dna repair enzyme in xeroderma pigmentosum: A retrospective study of eight cases

Case Reports in Dermatology

Volumn 6, Issue 3, 2014, Pages 222-226

  Giustini, Sandra ^a   Miraglia, Emanuele ^a   Berardesca, Enzo ^b   Milani, Massimo ^c   Calvieri, Stefano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c Isdin Medical Department   (Italy)

Author keywords

Non melanoma skin cancer; Photolyase; Sunscreen; Xeroderma pigmentosum

Indexed keywords

DEOXYRIBODIPYRIMIDINE PHOTOLYASE;

ACTINIC KERATOSIS; ADULT; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; RETROSPECTIVE STUDY; SKIN CARCINOMA; TOPICAL FILM FORMING MEDICAL DEVICE; TRANSDERMAL DRUG DELIVERY SYSTEM; TREATMENT DURATION; ULTRA HIGH ULTRAVIOLET RADIATION PROTECTION FILTER; XERODERMA PIGMENTOSUM;

EID: 84929464659     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000368182     Document Type: Article

References (15)

1. Kraemer K: Sunlight and skin cancer. Proc Natl Acad Sci USA 1997;94:11-14.
2. Griffiths HR, Mistry P, Herbert KE, Lunec J: Molecular and cellular effects of ultraviolet light-induced genotoxicity. Crit Rev Clin Lab Sci 1998;35:189-237.
3. Vink AA, Roza L: Biological consequences of cyclobutane pyrimidine dimers. J Photochem Photobiol 2001;65:101-104.
4. Kramer K, Lee M, Scot to J: Xeroderma pigmentosum. Arch Dermatol 1987;123:241-250.
5. Cleaver J: Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968;218:652-656.
6. Robbins JH, Kraemer KH, Lutzner MA: Xeroderma pigmentosum: An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974;80:221-248.
7. Kleijer WJ, Laugel V, Berneburg M, Nardo T, Fawcett H, Gratchev A, Jaspers NG, Sarasin A, Stefanini M, Lehmann AR: Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst) 2008;7:744-750.
8. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P: Effect of topically applied T4 endonuclease V in liposome s on skin cancer in xeroderma pigmentosum: A randomised study. Xeroderma Pigmentosum Study Group. Lancet 2001;357:926-929.
9. Gerkema MP, Davies WI, Foster RG, Menaker M, Hut RA: The nocturnal bottleneck and the evolution of activity patterns in mammals. Proc Biol Sci 2013;280:20130508.
10. Schul W, Jans J, Rijksen YM, Klemann KH, Eker AP, de Wit J, Nikaido O, Nakajima S, Yasui A, Hoeijmakers JH, Van Der Horst GT: Enhanced repair of cyclobutane pyrimidine dimers and improved UV resistance in photolyase transgenic mice. EMBO J 2002;21:4719-4729.
11. Puviani M, Ba rcella A, Milani M: Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer. G Ital Dermatol Venereol 2013;148:693-698.
12. Puig-ButilléJA, Malvehy J, Potrony M: Role of CPI-17 in restoring skin homoeostasis in cutaneous field of cancerization: Effects of topical application of a film-forming medical device containing photolyase and UV filters. Exp De rmatol 2013;22:494-496.
13. Lehmann AR McGibbon D Stefanini M: Xeroderma pigmentosum.Orphanet J Rare Dis 2011 6 70.
14. Dréno B, Amici JM, Basset-Segu in N, Cribier B, Claudel JP, Richard MA: Management of actinic keratosis: A practical report and treatment algorithm from AKTeam(TM) expert clinicians. J Eur Acad Dermatol Venereol 2014;28:1141-1149.
15. Stege H, Roza L, Vink AA, Grewe M, Ruzicka T, Grether-Beck S, Krutmann J: Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci USA 2000;97:1790- 1795.